BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Benazepril Hydrochloride And Hydrochlorothiazide patents expire, and when can generic versions of Benazepril Hydrochloride And Hydrochlorothiazide launch?
Benazepril Hydrochloride And Hydrochlorothiazide is a drug marketed by Ani Pharms, Apotex, Aurobindo Pharma Usa, Mylan Pharms Inc, Sandoz, and Sun Pharm Inds Ltd. and is included in seven NDAs.
The generic ingredient in BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is benazepril hydrochloride; hydrochlorothiazide. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the benazepril hydrochloride; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Benazepril Hydrochloride And Hydrochlorothiazide
A generic version of BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE was approved as benazepril hydrochloride; hydrochlorothiazide by ANI PHARMS on February 11th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
- What are the global sales for BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
- What is Average Wholesale Price for BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
Summary for BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 7 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Clinical Trials: | 8 |
| Patent Applications: | 10 |
| What excipients (inactive ingredients) are in BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE? | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE excipients list |
| DailyMed Link: | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Shanghai Jiao Tong University School of Medicine | Phase 4 |
| TSH Biopharm Corporation Limited | Phase 4 |
| Ranbaxy Laboratories Limited | N/A |
See all BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE clinical trials
Pharmacology for BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
| Drug Class | Angiotensin Converting Enzyme Inhibitor Thiazide Diuretic |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
| Physiological Effect | Decreased Blood Pressure Increased Diuresis |
